glp 1 drugs and alcohol consumption GLP-1 Use Reduction: Can It Really Help? GLP-1 medications: The next big
Description
BloodBrain Barrier (BBB) Protection In cerebrovascular contexts, GLP-1 agonists stabilize BBB integrity by upregulating tight junction proteins and reducing MMP-9 activity, potentially mitigating stroke-related damage and vascular dementia pathology [13]
10.1038/s41598-017-17718-y Sci
Saxon DR, Iwamoto SJ, Mettenbrink CJ, McCormick E, Arterburn D, Daley MF, et al
Besides improving glucose control, reducing body weight, and lowering arterial blood pressure (surrogate endpoints), the breakthroughs were the demonstration of a significant reduction in cardiovascular and renal events in patients with type 2 diabetes at high risk
